Skip to main content

Table 4 Number (percentage) of patients with diabetes having data recorded for each of the 12 indicators in 2006 and 2009, and relative increase (relative risk, RR, with 95% CI) in the proportion of patients with recorded data in 2009 with respect to 2006

From: Data collection of patients with diabetes in family medicine: a study in north-eastern Italy

  Performance indicator 2006 (N = 18,507) 2009 (N = 20,744) 2009 vs. 2006 2009 vs. 2006
n (%) n (%) crude
RR (95% CI)
adjustedc
RR (95% CI)
a Blood pressureb 1267 (6.8%) 1470 (7.1%) 1.04 (0.97, 1.12) 0.91 (0.85, 0.98)
b BMIa 4665 (25.2%) 6126 (29.5%) 1.27 (1.23, 1.32) 1.17 (1.14, 1.21)
c Smoking habitsa 730 (3.9%) 1034 (5.0%) 1.34 (1.21, 1.47) 1.25 (1.14, 1.37)
d Total cholesterola 5664 (30.6%) 8726 (42.1%) 1.37 (1.33, 1.41) 1.27 (1.23, 1.30)
e LDLa 2427 (13.1%) 3829 (18.5%) 1.37 (1.30, 1.44) 1.21 (1.16, 1.27)
f Microalbuminuriaa 1093 (5.9%) 3438 (16.6%) 2.69 (2.41, 3.02) 2.33 (2.11, 2.57)
g Creatininea 5482 (29.6%) 8376 (40.4%) 1.36 (1.31, 1.40) 1.26 (1.22, 1.29)
h Creatinine clearancea 173 (0.9%) 623 (3.0%) 2.90 (2.40, 3.51) 2.27 (1.90, 2.71)
i Glycated haemoglobinb 200 (1.1%) 453 (2.2%) 2.03 (1.70, 2.42) 1.60 (1.34, 1.90)
j Foot examinationa 32 (0.2%) 194 (0.9%) 6.18 (3.70, 10.33) 4.87 (2.97, 7.99)
k Eye examinationa 2148 (11.6%) 3593 (17.3%) 1.53 (1.45, 1.62) 1.30 (1.24, 1.37)
l Urine testa 4830 (26.1%) 7461 (36.0%) 1.36 (1.32, 1.41) 1.28 (1.24, 1.32)
  1. BMI body mass index, LDL low-density lipoprotein
  2. a≥ 1 registration/year
  3. b≥ 4 registrations/year
  4. cAdjusted for patient’s sex, age, antidiabetic therapy, other therapy